Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

altRX vs PlushCare

altRX and PlushCare both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
altRX logo

altRX

6.7
★★★☆☆3.4/5

Best for: semaglutide from $1149/month

Visit altRX →
VS
PlushCare logo

PlushCare

6.4
★★★☆☆3.2/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit PlushCare →

If you are choosing between altRX and PlushCare, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. altRX leads our six-part score, 6.7 to 6.4. One of the two has an FDA warning letter on record, covered below.

altRX vs PlushCare price

altRX and PlushCare start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide is cheaper at altRX ($249 a month vs $399 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, altRX prices compounded injections and brand-name pens, while PlushCare prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.

Where each one treats patients

altRX does not publish where it ships, and PlushCare lists 50 states.

Pricing

altRX

Compounded GLP-1 (semaglutide) starting tierCompounded
$149/mo
semaglutide
Compounded GLP-1/GIP (tirzepatide) starting tierCompounded
$249/mo
tirzepatide
Brand-name Ozempic®Brand-name
$1149/mo
semaglutide
Brand-name Mounjaro®Brand-name
$1249/mo
tirzepatide
Brand-name Zepbound®Brand-name
$1249/mo
tirzepatide
Brand-name Wegovy®Brand-name
$1579/mo
semaglutide

PlushCare

StartingCompounded
$149/mo
semaglutide

Range up to $299/mo

StartingCompounded
$399/mo
tirzepatide

Range up to $599/mo

What each price covers

altRX's price also covers the clinician visit, the medication itself and shipping, which PlushCare does not claim.

altRX is silent on lab work and coaching.

PlushCare is silent on shipping and coaching.

That matters most for the drug: unless PlushCare confirms otherwise, budget for medication on top of its listed price.

altRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

PlushCare

Covered by the monthly price

Medication

Charged on top

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Charged on top

Coaching

Not stated

Where each one scores higher

Overall, altRX scores 6.7 and PlushCare 6.4 out of 10.

altRX is stronger on value (5.0 vs 3.0), user experience (8.0 vs 7.0) and support (7.0 vs 0.0).

PlushCare is stronger on trust & safety (7.5 vs 3.5) and accessibility (10.0 vs 5.0).

Effectiveness is within half a point.

How we score

altRX

6.7/10

Overall

PlushCare

6.4/10

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.0

Trust & Safety15%

3.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
0.0

FDA warning letters

The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.

PlushCare has no FDA warning letter on record with us.

Features & Coverage

FeaturealtRXPlushCare
Starting Price$149/mo$149/mo
Features8 features8 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About altRX

Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.

Read our full altRX review →

About PlushCare

PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.

Read our full PlushCare review →

Pros & Cons

altRX

What we like

  • Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

PlushCare

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • Serves all 50 states
  • We found no FDA warning letters issued to PlushCare
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • Baseline bloodwork is required before a prescription

Watch-outs

  • Not included in the monthly price: medication, clinician visits, lab work
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: altRX

altRX wins this one, 6.7 to 6.4, above all for semaglutide from $1149/month. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose altRX if…

You want semaglutide from $1149/month and an opening price near $149 a month.

Choose PlushCare if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

altRX vs PlushCare: FAQ

Neither on the entry price: altRX and PlushCare both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
altRX does not publish where it ships; PlushCare lists 50 states. Confirm your state before paying.
Only altRX includes the clinician visit, the medication itself and shipping.
altRX has an open FDA warning letter from June 8, 2026. PlushCare has none.
No. Neither altRX nor PlushCare pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.